Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations
Recruiting
Observational Study
Epicardial Fat Tissue (EFT)
Chronic Non-Communicable Diseases (NCDs)
Visceral Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- National Medical Research Center for Therapy and Preventive Medicine · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Visceral obesity is a well-established risk factor for the development of chronic non-communicable diseases (NCDs). Epicardial fat tissue (EFT) is located on the surface of the myocardium and may directly affect cardiac function and contribute to structural and functional remodeling.
According to the literature, increased EFT thickness is associated with a wide range of NCDs, disease severity, an…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged 50-70 years undergoing transthoracic echocardiography in inpatient or outpatient settings;
* Ability and willingness to provide informed consent.
Exclusion Criteria:
* Refusal to sign informed consent;
* Inability to perform transthoracic echocardiography or po…
Contacts